<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC3228724/results/search/medproc/results.xml">
  <result pre="was given on an ambulatory basis and under directly observed" exact="therapy" post="using a decentralized network of providers. Patients not already"/>
  <result pre="often inconsistently reported [9], [10]. Although the use of antiretroviral" exact="therapy" post="(ART) with MDR-TB treatment has been shown to improve"/>
  <result pre="to promptly diagnose and appropriately manage adverse drug effects. Third," exact="therapy" post="followed internationally recommended guidelines with maximally effective drug combinations,"/>
  <result pre="rates remain largely unreported [28], [29]. Similarly, failure to initiate" exact="therapy" post="and default from treatment rates were high in this"/>
  <result pre="mortality of HIV/MDR-TB co-infected patients. Rapid scale-up of both antiretroviral" exact="therapy" post="and second line treatment for MDR-TB is needed to"/>
  <result pre="e7186 19779624 14 collab: World Health Organization (WHO) 2010 Antiretroviral" exact="therapy" post="for HIV infection in adults and adolescents. Recommendations for"/>
  <result pre="Palacios E Shin S Furin J et al. 2003 Community-based" exact="therapy" post="for multidrug-resistant tuberculosis in Lima, Peru. N Engl J"/>
 </snippets>
</snippetsTree>
